Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-01 Sale |
2024-04-03 7:39 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
5,446 | $32.12 | $174,926 | 70,137 (Direct) |
View |
| 2023-07-12 Sale |
2023-07-14 6:52 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
117,000 | $12.07 | $1,412,414 | 54,847 (Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 8:30 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
4,640 | $29.74 | $137,978 | 47,117 (Direct) |
View |
| 2023-01-26 Sale |
2023-01-30 4:05 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
37,254 | $45.08 | $1,679,510 | 438,559 (Direct) |
View |
| 2023-01-23 Sale |
2023-01-25 5:25 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
20,236 | $45.02 | $910,947 | 491,725 (Direct) |
View |
| 2023-01-18 Sale |
2023-01-20 4:18 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
47,195 | $45.14 | $2,130,382 | 274,332 (Direct) |
View |
| 2022-03-31 Sale |
2022-04-04 8:22 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
1,787 | $59.11 | $105,630 | 38,278 (Direct) |
View |
| 2021-06-30 Sale |
2021-07-02 6:01 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
30,000 | $122 | $3,660,000 | 307,750 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-30 6:00 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
45,000 | $107.69 | $4,846,016 | 337,750 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 5:40 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
25,000 | $81.78 | $2,044,485 | 365,250 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-07-01 Option Award |
2024-07-03 4:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
1,843 | $0 | 71,254 (Direct) |
View |
Ownership |
2024-06-06 6:52 pm |
N/A 2034-01-12 |
Rapport Therapeutics Inc. | RAPP | Burrell Terry-Ann Director |
0 | $0 | 35,027 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-05 6:12 pm |
N/A 2034-06-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
39,290 | $0 | 95,604 (Direct) |
View |
| 2024-04-26 Option Award |
2024-04-29 4:10 pm |
N/A 2034-04-26 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
37,500 | $0 | 107,637 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 5:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
1,467 | $0 | 56,314 (Direct) |
View |
| 2024-03-31 Option Award |
2024-04-02 4:10 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
27,500 | $0 | 75,583 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:05 pm |
N/A 2034-01-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
55,000 | $24.4 | 55,000 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:19 pm |
2024-06-16 2033-06-16 |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
37,836 | $0 | 650,549 (Direct) |
View |
| 2023-01-31 Option Award(A) |
2023-04-19 4:30 pm |
N/A 2033-01-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-01-31 Option Award |
2023-03-31 7:46 pm |
N/A 2033-01-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
40,000 | $0 | 71,277 (Direct) |
View |
| 2023-01-26 Exercise |
2023-01-30 4:05 pm |
N/A 2029-08-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
37,254 | $0 | 438,559 (Direct) |
View |
| 2023-01-26 Exercise |
2023-01-30 4:05 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
37,254 | $13.68 | 438,559 (Direct) |
View |
| 2023-01-23 Exercise |
2023-01-25 5:25 pm |
N/A 2029-08-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
20,236 | $0 | 491,725 (Direct) |
View |
| 2023-01-23 Exercise |
2023-01-25 5:25 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
20,236 | $13.68 | 491,725 (Direct) |
View |
| 2023-01-18 Exercise |
2023-01-20 4:18 pm |
N/A 2029-08-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
39,886 | $0 | 274,332 (Direct) |
View |
| 2023-01-18 Exercise |
2023-01-20 4:18 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
39,886 | $13.68 | 274,332 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 6:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
1,821 | $0 | 159,235 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-05 9:12 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
1,265 | $0 | 157,414 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 5:48 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
1,631 | $0 | 156,149 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:12 pm |
2023-06-14 2032-06-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
54,435 | $0 | 607,996 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 7:23 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
1,788 | $0 | 136,373 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 8:22 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
15,000 | $0 | 38,278 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 6:00 pm |
N/A 2032-01-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:41 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
763 | $0 | 134,585 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-05 8:33 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
629 | $0 | 133,822 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 5:00 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
382 | $0 | 133,193 (Direct) |
View |
| 2021-06-30 Exercise |
2021-07-02 6:01 pm |
N/A 2029-08-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
30,000 | $0 | 307,750 (Direct) |
View |
| 2021-06-30 Exercise |
2021-07-02 6:01 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
30,000 | $13.68 | 307,750 (Direct) |
View |
| 2021-06-28 Exercise |
2021-06-30 6:00 pm |
N/A 2029-08-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
45,000 | $0 | 337,750 (Direct) |
View |
| 2021-06-28 Exercise |
2021-06-30 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
45,000 | $13.68 | 337,750 (Direct) |
View |
| 2021-04-20 Conversion |
2021-04-22 7:38 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
840,626 | $0 | 803,121 (Direct) |
View |
| 2021-04-20 Other |
2021-04-22 7:38 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
126,561 | $0 | 803,121 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 7:23 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
18,750 | $0 | 543,749 (Direct) |
View |
Ownership |
2021-04-15 08:53 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
0 | $0 | 524,999 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 5:11 pm |
N/A 2031-03-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
52,500 | $0 | 59,809 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-05 5:40 pm |
N/A 2029-08-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
25,000 | $0 | 365,250 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-05 5:40 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
25,000 | $13.68 | 365,250 (Direct) |
View |
| 2020-09-18 Exercise |
2020-09-21 9:08 pm |
N/A 2029-08-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
7,309 | $0 | 390,250 (Direct) |
View |
| 2020-09-18 Exercise |
2020-09-21 9:08 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
7,309 | $13.68 | 390,250 (Direct) |
View |